scispace - formally typeset
M

Mona Saraiya

Researcher at Centers for Disease Control and Prevention

Publications -  258
Citations -  18861

Mona Saraiya is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Cervical cancer & Population. The author has an hindex of 57, co-authored 247 publications receiving 15391 citations. Previous affiliations of Mona Saraiya include American Society for Clinical Pathology.

Papers
More filters
Journal ArticleDOI

Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.

TL;DR: Notable, population-level impacts of HPV vaccination on genital warts and CIN 2/3 can occur within a few years after onset of vaccination, particularly among younger age groups, generally consistent with early reports of declines in genital wart declines.
Journal ArticleDOI

Risk of cervical precancer and cancer among uninsured and underserved women from 2009 to 2017.

TL;DR: The increased risk observed among women with HPV-positive, high-grade cytology results, who were never screened or who were not up-to-date with their cervical cancer screening, led to a recommendation in the management guidelines for immediate treatment among these women.
Journal ArticleDOI

Bolivian Health Providers' Attitudes Toward Alternative Technologies for Cervical Cancer Prevention: A Focus on Visual Inspection with Acetic Acid and Cryotherapy

TL;DR: Attitudes of Bolivian health professionals toward new technologies for cervical cancer prevention, focusing on VIA and cryotherapy are described to inform the development of strategies to expand the use of alternative cervical cancer screening methods in LAC and Bolivia.
Journal ArticleDOI

Cervical Cancer Screening Among Women Who Attend Sexually Transmitted Diseases (STD) Clinics: Background Paper for 2010 STD Treatment Guidelines

TL;DR: Important additions to the 2010 STD Treatment Guidelines include information on updated algorithms for screening and management of women and recommendations for use of liquid-based cytology and high-risk HPV testing.
Journal Article

Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States.

TL;DR: Current estimates and project potential reductions in the volume and cost of annual Pap tests administered at visits to physician office and hospital outpatient departments in light of cervical cancer screening changes and HPV vaccination are established.